ENTITY
Xiamen Amoytop Biotech Co Ltd

Xiamen Amoytop Biotech Co Ltd (688278 CH)

37
Analysis
Health Care • China
Xiamen Amoytop Biotech Co., Ltd. operates as a drug development company. The Company develops and sells protein drugs, interferon drugs, and other products. Xiamen Amoytop Biotech markets its products primarily throughout China with limited overseas.
more
•14 Jun 2026 11:10

STAR50 Jun 2026 Index Rebalance: Pre-Implementation Update

STAR50 enters implementation on 15 Jun 2026. We update post-announcement stock performance and discuss implementation trades.

Logo
148 Views
Share
•14 Jun 2026 10:15

A-Share Margin Trading Weekly (Jun 12th): GUOTAI HAITONG SECURITIES, EAST MONEY INFORMATION, BOE

We analyzed A-share margin trading positions report for the past week and highlighted GUOTAI HAITONG SECURITIES (601211 CH), EAST MONEY INFORMATION...

Logo
159 Views
Share
•31 May 2026 18:13

Quiddity STAR 50/100 Jun26 Results: 7/8 Correct for STAR 50, Some Surprises Among STAR 100 ADDs

We predicted 7/8 STAR 50 index changes correctly. However, there were some surprises among the STAR 100 ADDs which might have been due to the...

Share
•31 May 2026 14:10

STAR50 Jun 2026 Index Rebalance: Post-Announcement Positioning

STAR50 Jun 2026 post-announcement trading is live. We review individual-stock positioning across ADDs and DELETEs. The opening gap should guide...

Logo
166 Views
Share
•28 May 2026 13:28

Quiddity Leaderboard STAR 50/100 Jun26: Final Expectations; ~US$2.6bn Combined One-Way Flows

The STAR50/100 Jun26 index review results will be confirmed after market close on Friday 29th May 2026. In this insight, we have presented our...

Share
x